Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M91,413Revenue (TTM) $M21,222Net Margin (%)12.9Altman Z-Score3.8
Enterprise Value $M95,752EPS (TTM) $2.6Operating Margin %18.1Piotroski F-Score6
P/E(ttm)32.1Beneish M-Score-2.6Pre-tax Margin (%)15.9Higher ROA y-yY
Price/Book6.510-y EBITDA Growth Rate %13.6Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %-8.3Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow23.1y-y EBITDA Growth Rate %15.9ROA % (ttm)7.5Higher Current Ratio y-yN
Dividend Yield %2.5PEG--ROE % (ttm)18.5Less Shares Outstanding y-yY
Payout Ratio %79.0Shares Outstanding M1,103ROIC % (ttm)16.0Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

LLY is held by these investors:

LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2017-02-17Sell230,000$80.273.24view
Zulueta Alfonso GSVP& Pres., Emerging Markets 2017-02-06Sell15,000$77.666.71view
Rice Derica WEVP-Global Services and CFO 2017-02-03Sell11,162$77.147.43view
Zakrowski Donald AChief Accounting Officer 2017-02-02Sell2,000$77.526.9view
LILLY ENDOWMENT INC10% Owner 2017-02-01Sell220,000$77.357.14view
Zakrowski Donald AChief Accounting Officer 2016-12-16Sell1,000$72.1314.89view
TAI JACKSON PDirector 2016-12-16Buy1,375$72.6414.08view
Mahony SusanSVP & Pres., Lilly Oncology 2016-12-16Sell20,242$72.6514.07view
HOOVER R DAVIDDirector 2016-12-16Buy500$71.8515.34view
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM 2016-12-16Sell2,093$82.230.78view

Press Releases about LLY :

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
While Big Diabetes Stagnates, Smaller Companies Are Moving Faster Than Ever Feb 09 2017 
Eli Lilly’s Fiscal 2016 Earnings Feb 01 2017 
Top Insider Buys of the Week Dec 24 2016 
Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly Dec 10 2016 
52-Week Company Lows Nov 25 2016 
Novo Nordisk Is Being Ignored Oct 06 2016 
Sanofi Sues Merck Over Patent Infringement Sep 20 2016 
Eli Lilly's Future Is Changing Aug 30 2016 
Pharmaceuticals are the New Bonds Aug 30 2016 
Most Bought and Sold Stocks by Hedge Funds May 22 2016 

More From Other Websites
LILLY ELI & CO Financials Feb 25 2017
Eli Lilly & Co.’s Cardiovascular Franchise Feb 24 2017
Eli Lilly & Co.’s Endocrine Franchise Feb 24 2017
Performance of Eli Lilly & Co.’s Business Segments in 4Q16 Feb 24 2017
Eli Lilly & Co.’s Revenues in 4Q16 Feb 23 2017
In 'groundbreaking' deal, Harvard Pilgrim negotiates contracts to save on two pricey drugs Feb 23 2017
Eli Lilly CEO supports Trump's 'blueprint' for growth Feb 22 2017
[$$] Alzheimer’s: Pharma’s Great White Whale Is Still Worth Hunting Feb 22 2017
[$$] Lilly Asia Seeks Up to $450 Million for Fourth Fund Feb 21 2017
LILLY ELI & CO Files SEC form 10-K, Annual Report Feb 21 2017
[$$] Alzheimer's: Pharma's Great White Whale Is Still Worth Hunting Feb 20 2017
What's Driving Lilly's (LLY) Shares after 2016 Decline? Feb 16 2017
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Eli Lilly, T-Mobile, Oracle and Marathon... Feb 16 2017
DexCom Is a Great Healthcare Stock to Buy Now Feb 15 2017
Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show... Feb 15 2017
Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show... Feb 15 2017
Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next? Feb 15 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)